VITURA HEALTH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.115 AUD | +9.52% |
|
-28.12% | -54.90% |
| Apr. 26 | Vitura Health's Shares Jump 19% After Securing Injunction Order Over Code4 Spat | MT |
| Apr. 24 | Vitura Health's Services Agreement with Code4 at Risk of Termination; Shares Plunge 31% | MT |
Valuation
| Fiscal Period: Juni | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 8.755 | 13.52 | 137.7 | 286.6 |
| Enterprise Value (EV) 1 | -3.723 | 6.415 | 126.6 | 269 |
| P/E ratio | -1.58 x | -3.34 x | 20.2 x | 21.3 x |
| Yield | - | - | 4% | 1.94% |
| Capitalization / Revenue | 70.7 x | 7.99 x | 2.05 x | 2.44 x |
| EV / Revenue | -30.1 x | 3.79 x | 1.89 x | 2.29 x |
| EV / EBITDA | 0.91 x | -1.61 x | 12.6 x | 13.3 x |
| EV / FCF | 1,024,760 x | -1,693,554 x | 12,326,266 x | 41,372,383 x |
| FCF Yield | 0% | -0% | 0% | 0% |
| Price to Book | 0.65 x | 1.45 x | 5.27 x | 8.19 x |
| Nbr of stocks (in thousands) | 128,750 | 128,750 | 550,625 | 556,532 |
| Reference price 2 | 0.0680 | 0.1050 | 0.2500 | 0.5150 |
| Announcement Date | 8/28/20 | 8/27/21 | 8/28/22 | 8/22/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.4476 | - | 0.1238 | 1.693 | 66.99 | 117.3 |
| EBITDA 1 | 0.2014 | -2.864 | -4.095 | -3.985 | 10.09 | 20.19 |
| EBIT 1 | 0.1919 | -2.891 | -4.125 | -4.041 | 9.922 | 19.86 |
| Operating Margin | 42.88% | - | -3,330.34% | -238.7% | 14.81% | 16.93% |
| Earnings before Tax (EBT) 1 | 0.1923 | -2.958 | -3.99 | -4.206 | 9.745 | 20.05 |
| Net income 1 | 0.1503 | -2.914 | -3.937 | -4.049 | 6.013 | 13.81 |
| Net margin | 33.59% | - | -3,179.02% | -239.2% | 8.98% | 11.77% |
| EPS | - | -0.9635 | -0.0429 | -0.0314 | 0.0124 | 0.0242 |
| Free Cash Flow | - | -0.8272 | -3.633 | -3.788 | 10.27 | 6.503 |
| FCF margin | - | - | -2,933.7% | -223.78% | 15.34% | 5.54% |
| FCF Conversion (EBITDA) | - | - | - | - | 101.83% | 32.21% |
| FCF Conversion (Net income) | - | - | - | - | 170.88% | 47.09% |
| Dividend per Share | - | - | - | - | 0.0100 | 0.0100 |
| Announcement Date | 11/6/19 | 11/6/19 | 8/28/20 | 8/27/21 | 8/28/22 | 8/22/23 |
1AUD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: June | 2023 S1 | 2023 S2 |
|---|---|---|
| Net sales 1 | 39.85 | 38.38 |
| EBITDA 1 | 8.192 | 6.029 |
| EBIT | - | - |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | - | - |
| Net margin | - | - |
| EPS | - | - |
| Dividend per Share | - | - |
| Announcement Date | 2/12/23 | 8/22/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.04 | 2.04 | - | - | - | - |
| Net Cash position 1 | - | - | 12.5 | 7.1 | 11 | 17.6 |
| Leverage (Debt/EBITDA) | 0.2016 x | -0.7132 x | - | - | - | - |
| Free Cash Flow | - | -0.83 | -3.63 | -3.79 | 10.3 | 6.5 |
| ROE (net income / shareholders' equity) | - | 214% | -74.5% | -37% | 40% | 45.1% |
| ROA (Net income/ Total Assets) | - | -167% | -28.5% | -17.5% | 24% | 27.7% |
| Assets 1 | - | 1.74 | 13.8 | 23.18 | 25.05 | 49.92 |
| Book Value Per Share | - | -0.7000 | 0.1000 | 0.0700 | 0.0500 | 0.0600 |
| Cash Flow per Share | - | 0.0400 | 0.1100 | 0.0700 | 0.0300 | 0.0300 |
| Capex 1 | 0.1 | 0.01 | 0.12 | 0.04 | 0.37 | 0.93 |
| Capex / Sales | 23.29% | - | 97.05% | 2.37% | 0.55% | 0.79% |
| Announcement Date | 11/6/19 | 11/6/19 | 8/28/20 | 8/27/21 | 8/28/22 | 8/22/23 |
1AUD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -54.90% | 43.19M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- VIT Stock
- Financials Vitura Health Limited
